: Additional data for CLIP-Seq analysis. (A) Western blots of CELF2 and proteins that bind to related sequences in the starting extract from which the CLIP was done (T), the immunoprecipiated sample used for further CLIP processing (IP) and the proteins remaining after the IP reaction (FT). Note that the CELF1 antibody used for Western blot detects CELF2 when abundant in the stimulated samples. (B) Analysis of overlap of CELF2 peaks from unstimulated and stimulated JSL1 Jurkat cells compared to overlap of randomized reads, or overlap with two unrelated RBPs -hnRNP L and hnRNP A1. (C) Regression analysis of the number of tags from unstimulated cells versus the number of tags from stimulated cells for sequence regions covered by peaks identified in the stimulated cell samples. R>0.81.
Supplemental
: (A) Empirical cumulative distribution function (CDF) of dPSI values upon CELF2 depletion in stimulated cells for sets of exons that are not bound by CELF2 (grey, n = 1839), bound by CELF2 downstream only (green, n=161), or bound by CELF2 upstream only (red, n=144). Significant differences are observed between unbound and bound downstream (Rank-Sum twotailed p < 0.01), unbound and bound upstream (p < 0.001), or bound upstream and bound downstream (p < 6 x 10^-5) with shifts in dPSI values consistent with position dependent regulation." (B) Per nucleotide mean conservation (phastCons46way, placental mammals) in regions proximal to splice sites for CELF2 bound, CELF2 bound and regulated and CELF2 unbound set compared to a set of expressed alternative exons queried by RASL-seq. 
CELF2
Comp RNA:
Supplemental Figure S4 : Additional data demonstrating preferential binding of CELF2 to upstream intron of MKK7-E2. UV crosslinking as in Figure 6 with the Full MKK7-E2 RNA in the presence of increasing amounts (1, 5, 10 pmol) of unlabelled Up or Down RNA as competitor. Species corresponding to CELF2 is indicated, as is position of molecular weight markers. Up RNA competes CELF2 from binding to Full RNA, while Down RNA has no impact.
